safety results from phase 3b strong trial of durvalumab in patients with urinary tract carcinoma
Published 2 years ago • 41 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
2:10
strong: fixed-dose durvalumab for utc
-
1:00
trial of durvalumab for bladder cancer
-
2:49
first-in-human trial of medi1191 plus durvalumab in patients with advanced solid tumors
-
1:06
key trials in bladder cancer from asco gu 2022
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
9:17
clinical insights from outcomes in patients with upper vs lower urinary tract urothelial carcinoma
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
1:47
current and upcoming clinical trials in bladder cancer
-
10:05
pout: extended follow-up results
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
3:02
danube: pd-l1 as a predictor of survival in patients with muc
-
21:44
contemporary management of upper tract urothelial carcinoma
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma
-
0:50
role of vaccines in urothelial carcinoma
-
2:55
highlights of durvalumab for advanced bladder cancer
-
8:44
bladder cancer
-
12:59
vial presents: challenges in bladder cancer trials with dr. guru sonpavde
-
3:20
updates on the danube, keynote-361 and javelin studies
-
0:39
tiragolumab and atezolizumab in metastatic esophageal cancer